Leverage our comprehensive molecular oncology portfolio and experienced teams to access the right solutions for your lab’s needs. With easy-to-use instruments, intuitive software, and pre-designed assays—plus on-going support and a commitment to expanding our molecular oncology menu—we make it simpler for you to provide relevant oncology results that help make decisions. Find the perfect fit for your lab by choosing from our molecular oncology portfolio below.
Easier, more comprehensive MSI testing with automated calling, optional normal controls, and a 13-microsatellite marker panel to test for MSI associated with Lynch syndrome-related cancers and study immuno-therapy.
Comprehensive and fast whole-genome CNV assays to detect chromosomal arm aberrations, focal changes, LOH, cnLOH, and more from as little as 80 ng FFPE-derived DNA.
TaqMan Liquid Biopsy dPCR assays detect and quantify the most common cancer-related mutations (e.g., EGFR, BRAF, KRAS, PIK3CA, JAK2), as well as therapy-resistant mutations (e.g., EGFR T790M).
A whole-genome CNV assay to simultaneously detect copy number gains and losses, LOH, cnLOH, low-level mosaicism, ploidy, and more from hematological malignancy samples.
Enabling NGS analysis of multiple biomarker types (fusions, indels, SNVs, CNVs), Oncomine assays are part of an end-to-end workflow that includes simple, scalable sequencing with optimized bioinformatics and reporting.
Analyzing and interpreting molecular oncology data doesn’t need to be challenging. We offer easy-to-use data analysis software for each of our solutions.
For Research Use Only. Not for use in diagnostic procedures.